Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2010
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197915 Lapatinib intermediates
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197715 Piperidine derivatives
08/05/2010US20100197698 5-phenyl-3-pyridazinone derivative
08/05/2010US20100197686 Therapeutic compounds
08/05/2010US20100197685 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
08/05/2010US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197655 Sulfonamide derivatives
08/05/2010US20100197030 Xanthene dyes comprising a sulfonamide group
08/05/2010US20100196988 Bioreactive Agents
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010US20100196269 Spirocyclic heterocyclic derivatives and methods of their use
08/05/2010CA2751239A1 Azetidines as histamine h3 receptor antagonists
08/05/2010CA2751125A1 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010CA2746967A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
08/04/2010EP2213670A2 Epothilone derivatives
08/04/2010EP2213668A2 Imidazoles as aldosterone synthase inhibitors
08/04/2010EP2213167A1 Anthranilamide derivatives and their use for the control of insects and acari
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212291A1 Heterocycle phenyl amide t-type calcium channel antagonists
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
08/04/2010EP2212283A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2212282A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010EP2029540B1 Benzamide derivatives and uses related thereto
08/04/2010EP2010506B1 Diazepan derivatives modulators of chemokine receptors
08/04/2010CN1950362B Process for the preparation of tryptase inhibitors
08/04/2010CN1918141B Aminodibenzodioxin derivative and organic electroluminescent device using same
08/04/2010CN1824662B Substituted pyridine herbicides
08/04/2010CN101796047A luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof
08/04/2010CN101796046A Pyrimidine derivatives 934
08/04/2010CN101796031A Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
08/04/2010CN101792433A Method for synthesizing 1-((3-(5-nitro-2-furyl)allylidene)amino)-hydantoin
08/04/2010CN101792430A (Z) type tetrahydro-pyrimidine carboxylic ester derivative and preparation method thereof
08/03/2010US7767831 purified polylactic acid or glycolic acid-lactic acid copolymer; insert for drugs
08/03/2010US7767812 Crystals of pyrimidine compound and process for producing the same
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767704 viricides such as N-(3-Chloropropyl)-1-methyl-4-[({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazol-2-carboxamide, used for treating cytomegalovirus infections in humans or animals
08/03/2010US7767695 Substituted piperidines
08/03/2010US7767692 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010US7767194 Using cyanine dyes; in situ supplying to tumor cells
08/03/2010CA2598788C Indoline-sulfonamides compounds
08/03/2010CA2526228C Quinoline derivatives as phosphodiesterase inhibitors
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/03/2010CA2425165C A process for the preparation of bis-benzazolyl compounds
08/03/2010CA2227706C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
07/2010
07/29/2010WO2010085377A2 Hydroxamic acid derivatives
07/29/2010WO2010085246A1 2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase inhibitors
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084428A1 Substituted pyrazinone amides
07/29/2010WO2010084152A1 Novel bicyclic antibiotics
07/29/2010WO2010083732A1 N-acetylneuraminic acid compounds, pharmaceutical composition, preparation method and uses thereof
07/29/2010WO2010083720A1 Optical pure quinazoline compounds
07/29/2010WO2010083649A1 Bisarylurea derivatives and their use
07/29/2010WO2010065799A3 Amine substituted piperidine melanocortin receptor-specific compounds
07/29/2010US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity
07/29/2010US20100190990 Method for Producing 4-Aminobut-2-Enolides
07/29/2010US20100190831 Gpr120 receptor agonists and uses thereof
07/29/2010US20100190823 Therapeutic ((Bicylicheteroaryl)Imidazolyl) Methylheteroaryl Compounds
07/29/2010US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
07/29/2010US20100190789 Piperidine/piperazine derivatives
07/29/2010US20100190788 Amide derivatives as kinase inhitors
07/29/2010US20100189726 Lpaat-beta inhibitors and uses thereof
07/29/2010US20100186891 Nir-inert substrates comprising bis-oxodihydroindolylen-benzodifuranones
07/29/2010CA2750047A1 Novel bicyclic antibiotics
07/29/2010CA2748587A1 Substituted pyrazinone amides
07/29/2010CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/28/2010EP2210889A1 Process for producing pyrimidine compound
07/28/2010EP2210879A1 Pyrimidine derivatives and use thereof for combating undesired plant growth
07/28/2010EP2210876A1 Heterocyclic compound
07/28/2010EP1694668B1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010EP1369418B1 Quinazoline derivatives
07/28/2010CN1788000B Phthalazinone derivatives
07/28/2010CN101790515A trans-3-aza-bicyclo[3.1.0]hexane derivatives
07/28/2010CN101787020A Organic conjugated molecule capable of being processed by solution and application thereof in solar cells
07/28/2010CN101787019A Quinazoline derivatives
07/28/2010CN101787017A Optical pure quinazoline compound
07/28/2010CN101787008A N-acetyl neuraminic acid compounds, medicine compositions thereof and preparation methods and purposes thereof
07/27/2010US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids
07/27/2010US7763630 pyrimidinone compounds such as N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-2-(tetrahydrofuran-3-yl)-1,6-dihydropyrimidine-4-carboxamide, used for treating human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS)
07/27/2010US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors
07/27/2010US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors
07/27/2010US7763614 Isoquinoline potassium channel inhibitors
07/27/2010US7763608 Factor Xa inhibitors
07/27/2010US7763602 Drug resistant Mycobacterium tuberculosis
07/27/2010CA2466560C Acetylene derivatives having mglur5 antagonistic activity
07/27/2010CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor
07/22/2010WO2010083384A2 Non-peptidyl, potent, and selective mu opioid receptor antagonists
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 694